• Vapotherm Inc VAPO expects Q4 FY22 Revenues of $18.4 million to $18.7 million versus consensus of $16.32 million, with FY22 revenue expectations of $66 million to $67 million versus consensus of $64.47 million Dollar.
  • The company expects gross margin of 27% to 28% for the fourth quarter and 25% to 26% for fiscal 22.
  • For the fourth quarter of 2022, the Company expects non-GAAP operating expenses excluding impairment of long-lived assets and losses on disposal of property, plant and equipment to be between $20.9 million and $21.1 million.
  • Cash and cash equivalents were approximately $15.7 million as of December 31, 2022.
  • “Growth was primarily driven by a steady quarterly improvement in the U.S. single-use inventory turnover rate, which reached 70% of the pre-COVID three-year historical average in the fourth quarter, up from 60% in the third quarter,” said Joseph Army, president and CEO.
  • The company intends to reduce annual operating expenses from $100 million in 2021 to $60-$62 million in 2023 while making significant investments in future growth drivers.
  • For FY23, Vapotherm expects revenue of $77 million to $79 million, compared to the consensus of $76.44 million, with a gross margin of 48% to 50%.
  • In relation to the previously reported two delisting notices from the NYSE in 2022, the Company received a price correction notification letter from the NYSE stating that the Company’s share price was above the NYSE minimum requirement.
  • Vapotherm entered into a securities purchase agreement for a private placement financing for gross proceeds of approximately $23.0 million.
  • The company will issue 17.5 million shares and pre-funded warrants and purchase up to 4.4 million shares. The warrants are exercisable at a price of $1.17 per share.
  • Price promotion: VAPO shares are up 8.94% to $1.07 on the latest check Wednesday.


Source story